Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Fred E. Cohen
AddedMar 31, 2024
UpdatedMay 31, 2026
Fred E. Cohen

Fred E. Cohen

Board Member, Novotech

Crunchbase

Fred E. Cohen's Career

Novotech
Novotech

Sydney, New South Wales, AU

Board Member· Board
Genomic Health
Genomic Health

Redwood City, CA, US

Board Member· Board
UroGen Pharma
UroGen Pharma

New York City, NY, US

Board Member· Board
Progyny
Progyny

New York City, NY, US

Board Member· Board
Intellia Therapeutics
Intellia Therapeutics

Cambridge, MA, US

Board Member· Board
Kyverna Therapeutics
Kyverna Therapeutics

Emeryville, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Fred E. Cohen's Career

Novotech
Novotech
Late Stage Private$760M1.8k1996Sydney, New South Wales, AU
Board Member· Board

Leadership at Novotech

John MollerJohn MollerBoard Member
Veronica HollowayVeronica HollowayBoard Member
Joachim Herbert Von Roy \"Aki\"Joachim Herbert Von Roy \"Aki\"Board Member
Phillip Pryke \"Phil\"Phillip Pryke \"Phil\"Board Member
Genomic Health
Genomic Health
Acquired02000Redwood City, CA, US
Board Member· Board

Leadership at Genomic Health

Ginger GrahamGinger GrahamBoard Member
Julian C BakerJulian C BakerBoard Member
UroGen Pharma
UroGen Pharma
Public$422.1M2002004New York City, NY, US
Board Member· Board

Leadership at UroGen Pharma

Asher HolzerAsher HolzerFounder
Kate FalbergKate FalbergBoard Member
Liz BarrettLiz BarrettCEO
Stuart HoldenStuart HoldenBoard Member
Arie BelldegrunArie BelldegrunBoard Member
Cynthia ButittaCynthia ButittaBoard Member

Similar to UroGen Pharma

Uro-1Uro-1Winston-Salem, NC, USMedical Devicesest. 2017Uro-1Winston-Salem, NC, US · est. 2017

URO-1: Innovating urology and urogynecology with breakthrough office-based medical devices.

Seed · $4.1M7
Urica TherapeuticsUrica TherapeuticsBay Harbor Islands, FL, USPharmaceuticalsest. 2021Urica TherapeuticsBay Harbor Islands, FL, US · est. 2021

Urica Therapeutics, a Fortress Biotech subsidiary, develops pharmaceuticals for gout and kidney diseases.

Seed · $2.5M5
Bright UroBright UroAliso Viejo, CA, USMedical Devicesest. 2021Bright UroAliso Viejo, CA, US · est. 2021

Bright Uro: Pioneering next-gen urology diagnostic devices using advanced tech for actionable insights.

Series A · $29M12
Progyny
Progyny
Public$115.5M4002008New York City, NY, US
Board Member· Board

Leadership at Progyny

Kevin LoewkeKevin LoewkeCo-Founder
Lissa GoldensteinLissa GoldensteinCo-Founder
Renee Reijo PeraRenee Reijo PeraCo-Founder
Gina BartasiGina BartasiCo-Founder
Beth SeidenbergBeth SeidenbergBoard Member
Simeon GeorgeSimeon GeorgeBoard Member
Intellia Therapeutics
Intellia Therapeutics
Public$1.2B5982014Cambridge, MA, US
Board Member· Board

Leadership at Intellia Therapeutics

Nessan BerminghamNessan BerminghamCo-Founder
Rodolphe BarrangouRodolphe BarrangouCo-Founder
Jean-François FormelaJean-François FormelaBoard Member
Luciano MarraffiniLuciano MarraffiniCo-Founder
Andy MayAndy MayCo-Founder
Rachel HaurwitzRachel HaurwitzCo-Founder
Kyverna Therapeutics
Kyverna Therapeutics
Series B$170M922018Emeryville, CA, US
Board Member· Board

Leadership at Kyverna Therapeutics

Brian KotzinBrian KotzinBoard Member
Peter MaagPeter MaagCEO
Dan SpiegelmanDan SpiegelmanBoard Member
Jeffrey GreveJeffrey GreveFounder
Mark GenoveseMark GenoveseBoard Member
Ian ClarkIan ClarkBoard Member

Fred E. Cohen's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Fred E. Cohen

Kyle CerminaraKyle CerminaraBoard Member · FG Financial GroupMichael Scott CohenMichael Scott CohenBoard Member · TomsRahul MerchantRahul MerchantBoard Member · Global Cloud XchangeBob HaberBob HaberFounder · Proficio Capital PartnersDavid R GolobDavid R GolobBoard Member · Quest SoftwareAmy KruseAmy KruseBoard Member · Gilgamesh Pharmaceuticals